A randomized trial of the effects of nebulized albuterol on pulmonary edema in brain-dead organ donors

American Journal of Transplantation

Volumn 14, Issue 3, 2014, Pages 621-628

  Ware, L B ^a   Landeck, M ^b   Koyama, T ^a   Zhao, Z ^a   Singer, J ^c   Kern, R ^c   Neidlinger, N ^b   Nguyen, J ^b   Johnson, E ^b   Janz, D R ^a   Bernard, G R ^a   Lee, J W ^c   Matthay, M A ^c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b California Transplant Donor Network   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Albuterol; clinical trials; donor management; lung transplantation; pulmonary edema

Indexed keywords

PLACEBO; SALBUTAMOL; SODIUM CHLORIDE;

ADULT; ARTERIAL PRESSURE; ARTICLE; BRAIN DEATH; CAUSE OF DEATH; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; ETHNICITY; FEMALE; GENDER; HUMAN; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; ORGAN DONOR; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; OXYGENATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING; TACHYCARDIA; YOUNG ADULT;

ADULT; ALBUTEROL; BRAIN DEATH; BRONCHODILATOR AGENTS; CASE-CONTROL STUDIES; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG; LUNG TRANSPLANTATION; MALE; NEBULIZERS AND VAPORIZERS; OXYGEN CONSUMPTION; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY EDEMA; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS;

EID: 84896734653     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12564     Document Type: Article

References (28)

1. Valapour M, Paulson K, Smith JM, et al. OPTN/SRTR 2011 annual data report: Lung. Am J Transplant 2013; 13: S149-S177.
2. Edwards LB, Keck BM., Thoracic organ transplantation in the US. Clin Transpl 2002; 29-40.
3. Klein AS, Messersmith EE, Ratner LE, Kochik R, Baliga PK, Ojo AO., Organ donation and utilization in the United States, 1999-2008. Am J Transplant 2010; 10: 973-986.
4. Ojo AO, Heinrichs D, Emond JC, et al. Organ donation and utilization in the USA. Am J Transplant 2004; 4: S27-S37.
5. Rogers FB, Shackford SR, Trevisani GT, et al. Neurogenic pulmonary edema in fatal and nonfatal head injuries. J Trauma 1995; 39: 860-868.
6. Matthay MA, Folkesson HG, Clerici C., Lung epithelial fluid transport and the resolution of pulmonary edema. Physiol Rev 2002; 82: 569-600.
7. Ware LB, Fang X, Wang Y, Sakuma T, Hall TS, Matthay MA., Selected contribution: Mechanisms that may stimulate the resolution of alveolar edema in the transplanted human lung. J Appl Physiol 2002; 93: 1869-1874.
8. Ware LB, Wang Y, Fang X, et al. Assessment of lungs rejected for transplantation and implications for donor selection. Lancet 2002; 360: 619-620.
9. Perkins GD, McAuley DF, Thickett DR, Gao F., The beta-agonist lung injury trial (BALTI): A randomized placebo-controlled clinical trial. Am J Respir Crit Care Med 2006; 173: 281-287.
10. Perkins GD, Nathani N, McAuley DF, Gao F, Thickett DR., In vitro and in vivo effects of salbutamol on neutrophil function in acute lung injury. Thorax 2007; 62: 36-42.
11. Bosmann M, Grailer JJ, Zhu K, et al. Anti-inflammatory effects of beta2 adrenergic receptor agonists in experimental acute lung injury. FASEB J 2012; 26: 2137-2144.
12. Ware LB, Koyama T, Billheimer D, et al. Advancing donor management research: Design and implementation of a large, randomized, placebo-controlled trial. Ann Intensive Care 2011; 1: 20.
13. Rey MM, Ware LB, Matthay MA, et al. Informed consent in research to improve the number and quality of deceased donor organs. Crit Care Med 2011; 39: 280-283.
14. Atabai K, Ware LB, Snider ME, et al. Aerosolized beta2-adrenergic agonists achieve therapeutic levels in the pulmonary edema fluid of ventilated patients with acute respiratory failure. Intensive Care Med 2002; 28: 705-711.
15. Sakuma T, Folkesson HG, Suzuki S, Okaniwa G, Fujimura S, Matthay MA., Beta-adrenergic agonist stimulated alveolar fluid clearance in ex vivo human and rat lungs. Am J Respir Crit Care Med 1997; 155: 506-512.
16. Ware LB, Neyrinck A, O'Neal HR, et al. Comparison of chest radiograph scoring to lung weight as a quantitative index of pulmonary edema in organ donors. Clin Transplant 2012; 26: 65-71.
17. Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1994-2003. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA; University Renal Research and Education Association, Ann Arbor, MI, 2004.
18. Sekine Y, Waddell TK, Matte-Martyn A, et al. Risk quantification of early outcome after lung transplantation: Donor, recipient, operative, and post-transplant parameters. J Heart Lung Transplant 2004; 23: 96-104.
19. Knoben J, Anderson P., Handbook of clinical drug data. 7th ed. Hamilton: Drug Intelligence Publications, Inc., 1993.
20. O'Brien PC, Fleming TR., A multiple testing procedure for clinical trials. Biometrics 1979; 35: 549-556.
21. Lan KKG, DeMets DL., Discrete sequential boundaries for clinical trials. Biometrika 1983; 70: 659-663.
22. Hintze J. PASS. 2008. Available at: www.ncss.com. Accessed October 3, 2013.
23. Liang KY, Zeger SL., Regression analysis for correlated data. Annu Rev Public Health 1993; 14: 43-68.
24. Matthay MA, Brower RG, Carson S, et al. Randomized, placebo-controlled clinical trial of an aerosolized beta(2)-agonist for treatment of acute lung injury. Am J Respir Crit Care Med 2011; 184: 561-568.
25. Gao Smith F, Perkins GD, Gates S, et al. Effect of intravenous beta-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): A multicentre, randomised controlled trial. Lancet 2012; 379: 229-235.
26. Mascia L, Pasero D, Slutsky AS, et al. Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: A randomized controlled trial. JAMA 2010; 304: 2620-2627.
27. Perry R, Joseph MX, De Pasquale CG, et al. High-resolution transthoracic echocardiography of the left anterior descending coronary artery: A novel noninvasive assessment of coronary vasoreactivity. J Am Soc Echocardiogr 2008; 21: 134-138.
28. Barbato E, Piscione F, Bartunek J, et al. Role of beta2 adrenergic receptors in human atherosclerotic coronary arteries. Circulation 2005; 111: 288-294.